The scientific committee of I-OSI 2025 invite the submission of abstracts for e-poster presentations at the 6th Annual Congress of Immuno Oncology Society of India-IOSICON 2025.
Please register for the conference through the link provided before submission of the abstract.
The work/Research/Abstract should be related to Immuno-oncology.
Summaries of new, ongoing and updated research (Original work, Case report, hypothesis, good quality review, preliminary data, and thesis work) will be acceptable for submission and presentation.
One Delegate cannot submit More than 3 Abstracts.
Inappropriately structured or incomplete abstracts will not be accepted.
An abstract may not contain any illustrations, images. 1 figure and 1 table can be submitted if crucial to judge the quality of abstract.
Presenting author to be highlighted in bold and underline.
The abstract author will be notified by email about its acceptance and other details.
The abstract presenting author must register for the conference.
Accepted presenters must adhere to deadlines and guidelines, and they must promptly respond to communication.
Attractive awards for oral and poster presentation.
Last Date of Abstract Submission is 8th December 2024.
Abstract must be typed and presented in English and maximum 300 words (which includes Background, Methods, Results and Conclusions).
Use the Font type Calibri and Font Size 11/12
Abstracts should be structured to include the following 4 sections:
Title
Authors and Affiliation
Background Information
Methods, Results and Conclusions
For case reports, please structure the abstracts as Introduction, Description and Conclusions
Abstract categories are:
Clinical
Basic Sciences
Subcategories
Original Data
Case Series
Case Reports
Last date of submission: 8th December 2024
Date of acceptance notification:
Last date for registration of authors:
For any queries regarding abstract submission please write on iosicon2025@gmail.com
We look forward to your participation. Please take this opportunity to showcase your work in a national forum and interact with your colleagues.